EUVIMEDEUVIMED entdecken
Open Access

Dihydromyricetin Ameliorates Myocardial Ischemia–Reperfusion Injury by Modulating CKLF1 ‐Mediated Cardiomyocyte Pyroptosis

Yuting Lin, Yang Sun, Jinping Liang, Chen Chen, Qian Yan, Junpeng Long, Hanlong Wang, Zhunhong Zhang, Peiyi Li, Shanhe Qu, Jingbo Yu, Yan Gao iD und 10 weitere

Phytotherapy Research · 2026-08 · 40 (8) · 5277-5298

DOI: 10.1002/ptr.70364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 29.05.2026. Verfasst von Yuting Lin und 21 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Engineering Technology Center of Standardization and Function of Chinese Herbal Decoction Pieces, College of Pharmacy, Hunan University of Chin…. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Flavonols, Myocytes, Cardiac, Pyroptosis. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Outstanding Youth Project of Hunan Education Department, Changsha Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial ischemia–reperfusion injury (MIRI) remains a major clinical challenge due to limited therapeutic options and the risk of complications such as hemorrhage. Dihydromyricetin (DMY), a flavonoid derived from Vine tea, has shown cardioprotective effects, but its mechanism of action in MIRI is not fully understood. This study aimed to investigate the therapeutic effects of DMY on MIRI and elucidate the underlying molecular mechanisms. A rat model of MIRI was established by left anterior descending coronary artery ligation. Rats received DMY or the positive control diltiazem (DIL) for 7 days post‐injury. Cardiac damage was assessed by measuring cardiac troponin levels and histopathological analysis. The expression of chemokine‐like factor 1 (CKLF1) and its downstream signaling pathways was examined using molecular and biochemical approaches. The interaction between DMY and CKLF1 was further validated using a CKLF1 agonist (C27) and CKLF1‐knockout rats. CKLF1 expression was significantly upregulated in MIRI, correlating with inflammatory infiltration, tissue disorganization, and elevated cardiac troponin levels. Mechanistically, CKLF1 activation promoted phosphorylation of nuclear factor kappa‐B (NF‐κB) and subsequent assembly of the NLR family pyrin domain‐containing 3 (NLRP3) inflammasome, leading to caspase‐1‐dependent pyroptosis. DMY treatment attenuated these effects by downregulating CKLF1 expression and disrupting its interaction with C‐C chemokine receptor type 5 (CCR5) and NLRP3, thereby suppressing pyroptosis. Notably, activation of CKLF1 signaling by its agonist C27 reversed the protective effects of DMY. Moreover, while CKLF1 knockout modestly reduced pyroptosis‐related protein expression, the anti‐pyroptotic effect of DMY was abolished in knockout rats, indicating its dependence on CKLF1. These findings demonstrate that DMY alleviates MIRI by targeting the CKLF1/NF‐κB/NLRP3 axis, thereby inhibiting pyroptosis and preserving cardiomyocyte integrity. The anti‐pyroptotic effect of DMY is specifically dependent on CKLF1 expression. This study provides a novel mechanistic basis for developing targeted therapies against MIRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Reperfusion InjuryFlavonolsMyocytes, CardiacPyroptosisChemokinesMARVEL Domain-Containing ProteinsAnimalsRatsMaleRats, Sprague-DawleyNF-kappa BSignal TransductionDisease Models, Animal

Stichwörter der Autor:innen

C‐C chemokine receptor type 5 (CCR5)chemokine‐like factor 1 (CKLF1)dihydromyricetinmyocardial ischemia–reperfusion injurypyroptosis

Substanzen

FlavonolsdihydromyricetinNF-kappa BCklf protein, ratChemokinesMARVEL Domain-Containing Proteins

Autor:innen und Institutionen

  • Hunan Engineering Technology Center of Standardization and Function of Chinese Herbal Decoction Pieces, College of Pharmacy, Hunan University of Chinese Medicine, Changsha, China.
  • Department of Pharmacy, The First Hospital of Lanzhou University, Lanzhou, China.
  • Institute of Traditional Chinese and Zhuang-Yao Ethnic, Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
  • College of Pharmacy, Tianjin University of Chinese Medicine, Tianjin, China.
  • School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, China.
  • Technology Innovation Center/National Key Laboratory Breeding Base of Chinese Medicine Powders and Innovative Drugs, Hunan University of Chinese Medicine, Changsha, China.

ORCID-Profile: Yan Gao, Naihong Chen, Qidi Ai

Förderung

  • National Natural Science Foundation of China
  • Outstanding Youth Project of Hunan Education Department
  • Changsha Natural Science Foundation
  • Hunan Natural Science Foundation
  • Scientific Research Project of Hunan Provincial Administration of Traditional Chinese Medicine
  • Special Scientific and Technological Project for Comprehensive Utilization of Ampelopsis grossedentata Resources of Hunan Qiankun Biotechnology Co. Ltd.
  • Key Project of Hunan University of Chinese Medicine School level Scientific Research Fund
  • Hunan University of Chinese Medicine Discipline Construction Project

Zitieren

APA

Lin, Y., Sun, Y., Liang, J., Chen, C., Yan, Q., Long, J., Wang, H., Zhang, Z., Li, P., Qu, S., Yu, J., Gao, Y., Wang, H., Yang, S., Lin, M., Liu, X., Yao, J., Tian, Z., Chen, N., …, & Ai, Q. (2026). Dihydromyricetin Ameliorates Myocardial Ischemia–Reperfusion Injury by Modulating CKLF1 ‐Mediated Cardiomyocyte Pyroptosis. Phytotherapy Research, 40(8), 5277-5298. https://doi.org/10.1002/ptr.70364

Vancouver

Lin Y, Sun Y, Liang J, Chen C, Yan Q, Long J, et al. Dihydromyricetin Ameliorates Myocardial Ischemia–Reperfusion Injury by Modulating CKLF1 ‐Mediated Cardiomyocyte Pyroptosis. Phytotherapy Research. 2026;40(8):5277-5298. doi:10.1002/ptr.70364

BibTeX
@article{Lin2026,
  author = {Lin, Yuting and Sun, Yang and Liang, Jinping and Chen, Chen and Yan, Qian and Long, Junpeng and Wang, Hanlong and Zhang, Zhunhong and Li, Peiyi and Qu, Shanhe and Yu, Jingbo and Gao, Yan and Wang, Huiqin and Yang, Songwei and Lin, Meiyu and Liu, Xuan and Yao, Jiao and Tian, Zhifeng and Chen, Naihong and Yang, Yantao and Liu, Shasha and Ai, Qidi},
  title = {Dihydromyricetin Ameliorates Myocardial Ischemia–Reperfusion Injury by Modulating CKLF1 ‐Mediated Cardiomyocyte Pyroptosis},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {8},
  pages = {5277--5298},
  doi = {10.1002/ptr.70364}
}
Kostenlos starten →